Translate Bio, Inc.   Report issue

For profit Phase 2
Founded: Lexington MA United States (2016)
Status: Acquired by Sanofi-Aventis (2021)

Organization Overview

First Clinical Trial
2018
NCT03375047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Translate Bio, Inc.